δ-opioid receptor agonist reduces severity of postresuscitation myocardial dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 287, Issue 2 56-2, 2004, Pages

  Sun, Shijie ^a,b   Weil, Max Harry ^a,b   Tang, Wanchun ^a,b   Kamohara, Takashi ^a   Klouche, Kada ^a  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiac arrest; Cardiopulmonary resuscitation; Hibernation; Rat; Ventricular fibrillation

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE ANTAGONIST; PENTAZOCINE; PENTOBARBITAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DIET RESTRICTION; DISEASE SEVERITY; DRUG ACTIVITY; HEART INDEX; HEART VENTRICLE FIBRILLATION; HIBERNATION; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION;

ANIMALS; CARDIOMYOPATHIES; NALOXONE; NARCOTIC ANTAGONISTS; PENTAZOCINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RESUSCITATION; SEVERITY OF ILLNESS INDEX;

EID: 3242677909     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01171.2003     Document Type: Article

References (37)

1. Becker LB, Ostrander MP, Barrett J, and Kondos GT. CPR Chicago: outcome of cardiopulmonary resuscitation in a large metropolitan area-where are the survivors? Ann Emerg Med 20: 355-361, 1991.
2. Benedict PE, Benedict MB, Su TP, and Bolling SF. Opiate drugs and delta-receptor-mediated myocardial protection. Circulation 100: 357-360, 1999.
3. Bolling SF, Badhwar V, Schwartz CF, Oeltgen PR, Kilgore K, and Su TP. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. J Thorac Cardiovasc Surg 122: 476-481, 2001.
4. Brain Resuscitation Clinical Trial II Study Group A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med 324: 1125-1131, 1991.
5. Brown CG, Martin DR, and Pepe PE. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital. N Engl J Med 327: 1051-1055, 1992.
6. Brown CG and Werman HA. Adrenergic agonists during cardiopulmonary resuscitation. Resuscitation 19: 1-16, 1990.
7. Bruce DS, Bailey EC, Crane SK, Oeltgen PR, Horton ND, and Harlow HJ. Hibernation-induction trigger. I. Opioid-like effects of prairie dog plasma albumin on induced contractility of guinea pig ileum. Pharmacol Biochem Behav 58: 621-625, 1997.
8. Bruce DS, Bailey EC, Setran DP, Tramell MS, Jacobson D, Oeltgen PR, Horton ND, and Hellgren EC. Circannual variations in bear plasma albumin and its opioid-like effects on guinea pig ileum. Pharmacol Biochem Behav 53: 885-889, 1996.
9. Clark JA, Liu L, Price M, Hersh B, Edelson M, and Pasternak GW. Kappa opiate receptor multiplicity: evidence for two U50, 488-sensitive kappa 1 subtypes and a novel kappa 3 subtype. J Pharmacol Exp Ther 251: 461-468, 1989.
10. Diamond GA, Forrester JS, DeLuz PL, Wyatt HL, and Swan HJ. Postextrasystolic potentiation of ischemic myocardium by atrial stimulation. Am Heart J 95: 204-209, 1978.
11. Fryer RM, Wang Y, Hsu AK, and Gross GJ. Essential activation of PKC-δ in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol 280: H1346-H1353, 2001.
12. 2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med 17: 237-240, 1989.
13. Gazmuri RJ, Weil MH, Bisera J, Tang W, Fukui M, and McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 24: 992-1000, 1996.
14. Heusch G. Hibernation myocardium. Physiol Rev 78: 1055-1085, 1998.
15. Jennings RB, Hawkins HK, Lowe JE, Hill ML, Klotman S, and Reimer KA. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog. Am J Pathol 92: 187-214, 1978.
16. Katz AM and Reuter H. Cellular calcium and myocardial cell death. Am J Cardiol 44: 188-190, 1979.
17. Kern KB, Lancaster L, Goldman S, and Ewy GA. The effect of coronary artery lesions on the relationship between coronary perfusion pressure and myocardial blood flow during cardiopulmonary resuscitation in pigs. Am Heart J 120: 324-333, 1990.
18. Kette F, Weil MH, Gazmuri RJ, Bisera J, and Rackow EC. Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation. Crit Care Med 21: 901-906, 1993.
19. Lombardi G, Gallagher J, and Gennis P. Outcome of out-of-hospital cardiac arrest in New York City: the Pre-Hospital Arrest Survival Evaluation (PHASE) study. JAMA 271: 678-683, 1994.
20. Maldonado FA, Weil MH, Tang W, Bisera J, Gazmuri RJ, Johnson B, and D'Alessio A. Myocardial hypercarbic acidosis reduces cardiac resuscitability. Anesthesiology 78: 343-352, 1993.
21. McPherson BC and Yao Z. Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology 94: 1082-1088. 2001.
22. Oeltgen PR, Horton ND, Bolling SF, and Su TP. Extended lung preservation with the use of hibernation trigger factors. Ann Thorac Surg 61: 1488-1493, 1996.
23. Pellis T, Weil MH, Tang W, Sun SJ, Xie J, Song L, and Checchia P. Evidence favoring the use of alpha2-selective vasopressor agent for cardiopulmonary resuscitation. Circulation 108: 2716-2721, 2003.
24. Rahimtoola SH. Coronary bypass surgery for chronic angina. Circulation 65: 225-241, 1982.
25. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 72, Suppl V: V123-V135, 1985.
26. Schultz JE, Rose E, Yao Z, and Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 268: H2157-H2161, 1995.
27. Schultz JJ, Hsu AK, and Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29: 2187-2195, 1997.
28. ATP channels. Am J Physiol Heart Circ Physiol 274: H909-H914, 1998.
29. Stiell IG, Herbert PC, and Weitzman BN. High-dose epinephrine in adult cardiac arrest. N Engl J Med 327: 1045-1050, 1992.
30. Sun SJ, Weil MH, Tang W, Kamohara T, and Klouche K. Alpha- methylnorepinephrine, a selective alpha-2 adrenergic agonist for cardiac resuscitation. J Am Coll Cardiol 37: 951-956, 2001.
31. Tang W, Weil MH, Sun SJ, Gazmuri RJ, and Bisera J. Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 21: 1046-1050, 1993.
32. Tang W, Weil MH, Sun SJ, Noc M, Yang L, and Gazmuri RJ. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 92: 3089-3093, 1995.
33. ATP channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 279: H1609-H1615, 2000.
34. Tang W, Weil MH, Sun SJ, Yamaguchi H, Povoas HP, Marn Pernat A, and Bisera J. The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol 34: 815-822, 1999.
35. Tang W, Weil MH, Yu T, Klouche J, and Sun S. A delta opioid receptor agonist minimizes myocardial ischemia during cardiopulmonary resuscitation (Abstract). Crit Care Med 29: A18, 2001.
36. Wang LCH. Energetic and field aspects of mammalian torpor in the Richardson's ground squirrel. In: Strategies in Cold: Natural Torpidity and Thermogenesis, edited by Wang LCH and Hudson JW. New York: Academic, 1997, p. 109-145.
37. Wu D, Soong Y, Zhao GM, and Szeto HH. A highly potent peptide analgesic that protects against ischemia-reperfusion-induced myocardial stunning. Am J Physiol Heart Circ Physiol 283: H783-H791, 2002.